Significantly lower infection fatality rates associated with SARS-CoV-2 Omicron (B.1.1.529) infection in children and young people: Active, prospective national surveillance, January-March 2022, England.

Hani, Erjola; Bertran, Marta; Powell, Annabel; Williams, Hannah; Birrell, Paul; DeAngelis, Daniela; Ramsay, Mary E; Oligbu, Godwin; Ladhani, Shamez N

Hani, Erjola; Bertran, Marta; Powell, Annabel; Williams, Hannah; Birrell, Paul; DeAngelis, Daniela; Ramsay, Mary E; Oligbu, Godwin; Ladhani, Shamez N.

Hani E; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
Bertran M; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
Powell A; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
Williams H; Joint Modelling Team (JMT), UK Health Security Agency, UK; Emergency Preparedness, Response and Resilience, UK Health Security Agency, Porton Down, SP4 0JG, UK.
Birrell P; Joint Modelling Team (JMT), UK Health Security Agency, UK; MRC Biostatistics Unit, University of Cambridge, School of Clinical Medicine, Cambridge Institute of Public Health, Cambridge, United Kingdom; Statistical Modelling and Economics, UK Health Security Agency, Colindale, United Kingdom.
DeAngelis D; MRC Biostatistics Unit, University of Cambridge, School of Clinical Medicine, Cambridge Institute of Public Health, Cambridge, United Kingdom.
Ramsay ME; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
Oligbu G; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, United Kingdom; Paediatric Infectious Diseases Research Group, St George's University of London, London, United Kingdom.
Ladhani SN; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, United Kingdom; Paediatric Infectious Diseases Research Group, St George's University of London, London, United Kingdom. Electronic address: shamez.ladhani@ukhsa.gov.uk.

J Infect ; 86(4): 397-398, 2023 04.

Artículo en Inglés | MEDLINE | ID: covidwho-2210849

Asunto(s)

COVID-19; SARS-CoV-2; Humanos; Niño; Adolescente; Estudios Prospectivos; Inglaterra/epidemiología

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Estudio de cohorte / Estudio observacional / Estudio pronóstico Tópicos: Variantes Límite: Adolescente / Niño / Humanos País/Región como asunto: Europa Idioma: Inglés Revista: J Infect Año: 2023 Tipo del documento: Artículo País de afiliación: J.jinf.2023.01.032

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google